Beyond its secretion by osteocytes, FGF-23 was discovered to be expressed in cardiac myocytes and cardiac fibroblasts under pathologic conditions such as myocardial infarction, LV pressure overload and heart failure [19]. This evidence concerns the gene FGF23 and heart failure.